| Literature DB >> 23704993 |
Bertrand Genard1, Philippe Miner, Jean-Louis Nicolas, Dario Moraga, Pierre Boudry, Fabrice Pernet, Réjean Tremblay.
Abstract
BACKGROUND: Bacterial infections are common in bivalve larvae and can lead to significant mortality, notably in hatcheries. Numerous studies have identified the pathogenic bacteria involved in such mortalities, but physiological changes associated with pathogen exposure at larval stage are still poorly understood. In the present study, we used an integrative approach including physiological, enzymatic, biochemical, and molecular analyses to investigate changes in energy metabolism, lipid remodelling, cellular stress, and immune status of Crassostrea gigas larvae subjected to experimental infection with the pathogenic bacteria Vibrio coralliilyticus.Entities:
Mesh:
Year: 2013 PMID: 23704993 PMCID: PMC3660371 DOI: 10.1371/journal.pone.0064534
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Details of genes and primers used in the quantitative real-time PCR relative expression analysis.
| Genes | Label | GENBANK | Function | Forward primer (5′-3′) | Reverse primer (5′-3′) |
| a-agglutinin attachment subunit | AGL | CU984122 | Non-self recognition (lectin family) |
|
|
| Annexin 6 | ANX6 | CU989663 | Apoptose, inflammation response |
|
|
| c-type lectin-1 | cLEC | CU992287 | Non-self recognition (lectin family) |
|
|
| Cg-defensin 2 | Defh2 | AJ565499 | Antimicrobial peptide |
|
|
| Cg-DRAC3 | DRAC3 | BQ427023 | Haemocytes proliferation |
|
|
| ECSIT | ECSIT | BQ427193 | Immune response signalling (NF-KB) |
| CGTGCGAGGGCATATAGAG1TTG |
| Galectin 8 | Gal8 | BQ427054 | Non-self recognition (lectin family) |
|
|
| Cg-LBI/BPI (LPS binding/bactericidal-permeability-increasing protein) | LBP/BPI | AY165040 | Non-self recognition (LPS binding protein) |
|
|
| Mitogen activated protein kinase kinase 1 | MAPK | CU996721 | Immune response signaling |
|
|
| Cg-MyD88 (Myeloid differentiation primary response (88)) | MYD88 | DQ530619 | Immune response signaling (NF-KB) |
|
|
| Cg-REL | REL | AY039648 | Immune response signaling (NF-KB) |
|
|
| Cg-TAL (hematopoietic transcription factors) | TAL | AY039650 | Haemocyte proliferation |
|
|
| Cg-TIMP (tissue inhibitor metalloproteinase) | TIMP | AF321279 | Metalloproteinase inhibitor |
|
|
| cg-TRAF (TNF receptor associated factor) | TRAF | BQ426746 | Immune response signaling (NF-KB) |
|
|
| Arachidonate 15-lipoxygenase | AA15LX | CU998478 | Eicosanoide synthesis |
|
|
| Acyl-CoA synthetase | ACS | CU992135 | Fatty acid oxidation |
|
|
| Acyl-CoA dehydrogenase | ADH | FP001142 | Fatty acid oxidation |
|
|
| Stearoyl-desaturase 5 | Delta 5 | CU997931 | Fatty acid desaturation |
|
|
| Fatty acid desaturase 2 | Delta 6 | CU994528 | Fatty acid desaturation |
|
|
| Delta 9 desaturase | Delta 9 | CX069227 | Fatty acid desaturation |
|
|
| Enoyl-hydratase isomerase family protein | ECH | CU989620 | Fatty acid oxidation |
|
|
| Enolase | Enolase | CU986328 | Energy metabolism (glycolysis) |
|
|
| Adipolipin | Lipstor | CU996665 | Fatty acid strorage |
|
|
| Phosphatidylcholine transferase | Pctrans | CU997534 | Lipids class remodelling |
|
|
| Phospholipase a2 receptor 1 | PLA2 | CU994900 | Eicosanoides synthesis |
|
|
| Phospholipase delta 1 | PLD1 | CU993057 | Lipids class remodelling |
|
|
| Phosphatidylserine decarboxylase | Psdec | CU990331 | Lipids class remodelling |
|
|
| ATP synthase f0 subunit 6 | AS6 | EE677700 | Energy metabolism (electron chain transport) |
|
|
| Cytochrome c oxidase subunit i | CCOi | FP001743 | Energy metabolism (electron chain transport) |
|
|
| Citrate synthase | CS-G | CG1753 | Energy metabolism (acid citric cycle) |
|
|
| Glutamine Synthetase | GS | CG1753 | Amino acid synthesis |
|
|
| Mitochondrial nadh:ubiquinone oxidoreductase | NADHox | CU999020 | Energy metabolism (electron chain transport) |
|
|
| Catalase | CAT-G | CU996492 | Antioxidant defenses |
|
|
| Superoxide dismutase extracellular | ecSOD | CU999489 | Antioxidant defenses |
|
|
| Glutathione peroxidase 3 | GPX3 | CU994955 | Antioxidant defenses |
|
|
| Glutathione peroxidase 5 | GPX5 | CU988021 | Antioxidant defenses |
|
|
| Glutathione reductase | GR-G | FP000015 | Antioxidant defenses |
|
|
| Heat Shock protein 70 | HSP70 | CX069205 | Cytoprotection (chaperon protein) |
|
|
| Metallothionein | MT | CU998632 | Cytoprotection |
|
|
| Peroxiredoxin 4 | PRDX4 | FP005664 | Antioxidant defenses |
|
|
| Peroxiredoxin 5 | PRDX5 | CU986700 | Antioxidant defenses |
|
|
| Peroxiredoxin 6 | PRDX6 | CU984218 | Antioxidant defenses |
|
|
| Pernin | PRN | CD526735 | Cytoprotection (metals chelator) |
|
|
| Superoxide dismutase | SOD-G | FP005332 | Antioxidant defenses |
|
|
Figure 1Mortality and clearance rate for Pacific oyster Crassostrea gigas larvae as a function of experiment duration and bacterial challenge.
Larvae were challenged with Vibrio coralliilyticus for a period of 24 h or 48 h. Data from different treatments were pooled when this effect was not significant. Chal: challenged larvae; Unchal: unchallenged larvae. Data are means±SD of duplicate tanks. Different letters indicate significant differences.
Figure 2DGGE gels performed with 16 s cDNA extracted from larvae (L) and surrounding water (W).
Profiles were compared with (Chal) or without (Unchal) bacterial challenge and after 24 h and 48 h of experiment. The cDNA from reference sample (Ref), diet (D) and bacterial control (B) was used as ladder. Due to their high similarity, cDNA from duplicate samples were pooled. B1 and 2 correspond to the retrieved bands used to Vibrio coralliilyticus detection by sequencing analysis.
Figure 3RDA ordination biplot representing the significant (p<0.05) challenge effect after 24 (Chal24) and 48 h (Chal48) as explanatory variables (arrows) on selected response variables (lines) related to energy metabolism (red), lipids (blue), cellular stress (green), and immunity (pink).
Response variables related to larval performance and biochemical analysis were formatted in normal text, to enzymatic analysis in bold and to molecular analysis in italic. Black symbols: challenged larvae, white symbols: unchallenged larvae, squares: 24 h of exposure, circles: 48 h of exposure. Response variables abbreviations: -A, enzymatic activity; -G, gene expression; N-, neutral lipids; P-, polar lipids; Σ, sum of; cLEC, c-type lectin-1; AGL, a-agglutinin attachment subunit; LBP/BPI, LPS binding/bactericidal-permeability-increasing protein; MYD88, Myeloid differentiation primary response (88); TRAF, TNF receptor associated factor; REL, REL protein; DRAC3, drosophila rho GTPase 3; TAL, hematopoietic transcription factors; TIMP, tissue inhibitor metalloproteinase; Defh2, defensine 2; GR, glutathione reductase; SOD, superoxide dismutase; CAT, catalase; GPX5, glutathione peroxidase 5; PRDX4-5, peroxiredoxine 4 and 5; PRN, Pernin; HSP70, Heat shock protein 70; NADHOX, Mitochondrial nadh:ubiquinone oxidoreductase; CCOi, Cytochrome c oxidase subunit i; AS6, ATP synthase f0 subunit 6; PK, pyruvate kinase; CCO, cytochrome c oxidase; ADH, Acyl-CoA dehydrogenase; ECH, Enoyl-hydratase isomerase family protein; ACS, Acyl-CoA synthetase; Lipstor, Adipophilin; Delta5, Stearoyl-desaturase 5; Delta6, Fatty acid desaturase 2; PLA2, Phospholipase a2 receptor 1; PLD1, Phospholipase delta 1; AA15LX, Arachidonate 15-lipoxygenase; TOT, total lipids; PI, phosphatidylinositol; LPC, lysophosphatidylcholine; TAG, triacylglycerols; FFA, free fatty acids; AA, arachidonic acid; EPA, eicosapentaenoic acid; DPA, Docosapentaenoic acid; DHA, Docosahexaenoic acid; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; NMI, non-methylene–interrupted fatty acids; Pind, peroxidation index; Protein, total proteins content; Feeding, feeding activity; Mortality, mortality rate.
Summary of means (± STD) and statistics for parameters related to energetic metabolism.
| Mean±STD | Multiple comparisons | |||||||||
| Analyses | RV | Unity | 24 h Chal | 24 h Unchal | 48 h Chal | 48 h Unchal | 24 h Chal | 24 h Unchal | 48 h Chal | 48 h Unchal |
| Gene expression | AS6 | Relative expression | 0.86±0.09 | 0.67±0.32 | 1.26±0.73 | 9.60±2.92 | b | b | b | a |
| CCOi | Relative expression | 0.83±0.1 | 0.61±0.12 | 0.76±0.21 | 2.72±0.09 | b | b | b | a | |
| NADHox | Relative expression | 1.10±0.19 | 0.63±0.3 | 0.89±0.03 | 2.27±0.67 | b | b | b | a | |
| Enzymatic activity | CCO-A | pmol larve− min−1 | 0.45±0.05 | 0.49±0.04 | 0.47±0.03 | 0.62±0.02 | b | b | b | a |
| PK-A | pmol larve−1 min−1 | 5.13±0.62 | 3.22±0.06 | 6.05±0.41 | 8.69±0.32 | b | c | b | a | |
| Biochemical content | Protein | ng protein larva−1 | 40.9±1.57 | 37.86±0.33 | 38.01±0.21 | 43.43±2.49 | ab | b | b | a |
Multiple comparisons show the significant differences (letters) between each combination of treatments. Abbreviations: RV, response variable name in RDA biplot, 24 and 48 h chal, larvae challenged during 24 or 48 h; 24 and 48 h unchal, unchallenged larvae after 24 and 48 h. Response variables abbreviations: NADHOX, Mitochondrial nadh:ubiquinone oxidoreductase; CCOi, Cytochrome c oxidase subunit i; AS6, ATP synthase f0 subunit 6; PK-A, pyruvate kinase activity; CCO-A, cytochrome c oxidase activity; Protein, total proteins content.
Summary of means (± STD) and statistics for parameters related to lipids.
| Mean±STD | Multiple comparisons | |||||||||
| Analyses | RV | Unity | 24 h Chal | 24 h Unchal | 48 h Chal | 48 h Unchal | 24 h Chal | 24 h Unchal | 48 h Chal | 48 h Unchal |
| Biochemical content | N-Tot | ng lipids larva−1 | 4.71±1.1 | 4.35±0.89 | 2.09±0.13 | 4.70±0.23 | a | a | b | a |
| FFA | mass % | 2.53±0.02 | 3.07±0.15 | 6.51±0.08 | 2.16±0.03 | c | b | a | d | |
| TAG | mass % | 79.59±1.69 | 78.47±2.49 | 71.28±0.94 | 80.39±3.12 | a | a | b | a | |
| N-EPA | mass % | 4.72±0.31 | 4.90±0.01 | 5.89±0.05 | 4.83±0.25 | b | b | a | b | |
| N-ΣPUFA | mass % | 49.77±1.12 | 50.72±0.39 | 50.50±0.39 | 48.13±0.17 | ab | a | a | b | |
| N-Pind | - | 219±6 | 225±3 | 230±4 | 217±2 | ab | a | a | b | |
| LPC | mass % | 4.04±0.98 | 6.7±0.23 | 5.31±1.44 | 10.26±1.12 | b | b | b | a | |
| PI | mass % | 18.14±0.84 | 15.06±2.02 | 17.03±0.87 | 13.84±1.98 | a | ab | a | b | |
| P-AA | mass % | 2.43±0.09 | 2.33±0.01 | 2.12±0.09 | 3.86±0.12 | b | b | b | a | |
| P-DPA | mass % | 2.54±0.17 | 2.86±0.06 | 2.18±0.07 | 3.53±0.05 | c | b | d | a | |
| P-DHA | mass % | 19.64±0.69 | 19.65±0.01 | 19.95±0.01 | 22.97±1.15 | b | b | b | a | |
| P-ΣNMI | mass % | 10.91±0.09 | 8.14±0.51 | 11.62±0.22 | 7.53±0.25 | a | b | a | b | |
| P-ΣMUFA | mass % | 21.75±0.30 | 24.41±1.03 | 24.28±0.24 | 19.79±1.53 | b | a | ab | b | |
| P-ΣPUFA | mass % | 58.81±0.67 | 58.40±0.84 | 58.22±0.07 | 63.84±1.45 | b | b | b | a | |
| P-Pind | - | 292±7 | 301±6 | 293±1 | 333±12 | b | b | b | a | |
| Gene expression | AA15LX | Relative expression | 2.19±0.57 | 1.37±0.35 | 8.76±3.08 | 1.69±0.47 | b | b | a | b |
| ADH | Relative expression | 2.94±0.20 | 1.99±0.97 | 5.90±1.93 | 1.96±0.28 | b | b | a | b | |
| Delta5 | Relative expression | 0.58±0.14 | 0.40±0.36 | 1.64±0.2 | 0.47±0.19 | b | b | a | b | |
| Delta6 | Relative expression | 0.54±0.01 | 0.15±0.06 | 2.67±0.85 | 0.27±0.01 | b | b | a | b | |
| ECH | Relative expression | 2.89±1.38 | 0.55±0.22 | 4.09±0.38 | 0.67±0.39 | a | b | a | b | |
| Lipstor | Relative expression | 0.47±0.43 | 0.23±0.12 | 1.58±0.10 | 1.43±0.06 | b | b | a | a | |
| PLA2 | Relative expression | 0.51±0.46 | 0.16±0.09 | 2.17±0.59 | 0.09±0.04 | b | b | a | b | |
| PLD1 | Relative expression | 1.56±0.92 | 1.5±0.24 | 5.4±0.5 | 1.96±0.67 | b | b | a | b | |
Multiple comparisons show the significant differences (letters) between each combination of treatments. Abbreviations: RV, response variable coding in RDA biplot, 24 and 48 h chal, larvae challenged during 24 or 48 h; 24 and 48 h unchal, unchallenged larvae after 24 and 48 h. Response variables abbreviations: N-, neutral lipids; P-, polar lipids; Σ, sum of; TOT, total lipids; PI, phosphatidylinositol; LPC, lysophosphatidylcholine; TAG, triacylglycerols; FFA, free fatty acids; AA, arachidonic acid; EPA, eicosapentaenoic acid; DPA, Docosapentaenoic acid; DHA, Docosahexaenoic acid; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; NMI, non-methylene–interrupted fatty acids; Pind, peroxidation index; ADH, Acyl-CoA dehydrogenase; ECH, Enoyl-hydratase isomerase family protein; ACS, Acyl-CoA synthetase; Lipstor, Adipophilin; Delta5, Stearoyl-desaturase 5; Delta6, Fatty acid desaturase 2; PLA2, Phospholipase a2 receptor 1; PLD1, Phospholipase delta 1; AA15LX, Arachidonate 15-lipoxygenase.
Summary of means (± STD) and statistics for parameters related to immunity and oxidative stress.
| Mean±STD | Multiple comparisons | |||||||||
| Analyses | RV | Unity | 24 h Chal | 24 h Unchal | 48 h Chal | 48 h Unchal | 24 h Chal | 24 h Unchal | 48 h Chal | 48 h Unchal |
| Gene expression | AGL | Relative expression | 0.77±0.19 | 0.33±0.35 | 4.25±0.69 | 0.29±0.27 | b | b | a | b |
| CAT-G | Relative expression | 3.04±0.40 | 0.65±0.07 | 7.45±0.70 | 1.72±1.06 | b | b | a | b | |
| cLEC | Relative expression | 3.44±0.52 | 0,01±0,01 | 0.09±0.03 | 0.01±0,01 | a | b | b | b | |
| Defh2 | Relative expression | 0.60±0.26 | 0.14±0.04 | 1.81±0.49 | 0.30±0.03 | b | b | a | b | |
| DRAC3 | Relative expression | 1.17±0.42 | 2.73±0.47 | 1.10±0.03 | 0.59±0.2 | b | a | b | b | |
| GPX5 | Relative expression | 1.59±0.08 | 0.83±0.53 | 2.7±0.21 | 1.74±0.07 | b | b | a | b | |
| GR-G | Relative expression | 0.57±0.24 | 0.13±0.02 | 2.19±0.66 | 0.15±0.17 | b | b | a | b | |
| HSP70 | Relative expression | 1.24±0.95 | 1.02±0.46 | 5.79±1.50 | 0.83±0.06 | b | b | a | b | |
| LBP/BPI | Relative expression | 8.28±2.34 | 1.50±0.34 | 8.86±4.31 | 2.14±0.9 | a | b | a | ab | |
| MYD88 | Relative expression | 11.33±1.09 | 1.58±1.39 | 2.01±0.17 | 0.46±0.39 | a | b | b | b | |
| PRDX4 | Relative expression | 0.45±0.3 | 0.36±0.26 | 2.79±0.14 | 1.59±0.25 | c | c | a | b | |
| PRDX5 | Relative expression | 0.79±0.06 | 0.86±0.89 | 2.61±0.19 | 0.82±0.10 | b | b | a | b | |
| PRN | Relative expression | 0.65±0.1 | 0.09±0.04 | 1.64±0.30 | 0.67±0.21 | b | c | a | b | |
| REL | Relative expression | 0.96±0.59 | 0.63±0.21 | 3.61±0.61 | 1.81±0.31 | b | b | a | b | |
| SOD-G | Relative expression | 0.64±0.52 | 0.19±0.13 | 4.18±0.86 | 0.47±0.38 | b | b | a | b | |
| TAL | Relative expression | 0.37±0.28 | 0.18±0.05 | 1.81±0.73 | 0.37±0.06 | b | b | a | b | |
| TIMP | Relative expression | 1.55±0.39 | 0.35±0.11 | 6.03±1.58 | 1.68±0.71 | b | b | a | b | |
| TRAF | Relative expression | 0.45±0.05 | 0.52±0.09 | 3.52±0.59 | 0.95±0.85 | b | b | a | b | |
| Enzymatic activity | CAT-A | pmol larve−1 min−1 | 102.51±5.19 | 86.86±5.89 | 123.28±0.55 | 93.72±3.15 | b | b | a | b |
| SOD-A | pU larve−1 min−1 | 1947±328 | 1549±21 | 2212±133 | 1146±378 | a | ab | a | b | |
Multiple comparisons show the significant differences (letters) between each combination of treatments. Abbreviations: RV, response variable coding in RDA biplot, 24 and 48 h chal, larvae challenged during 24 or 48 h; 24 and 48 h unchal, unchallenged larvae after 24 and 48 h. Response variables abbreviations: -A, enzymatic activity; -G, gene expression cLEC, c-type lectin-1; AGL, a-agglutinin attachment subunit; LBP/BPI, LPS binding/bactericidal-permeability-increasing protein; MYD88, Myeloid differentiation primary response (88); TRAF, TNF receptor associated factor; REL, REL protein; DRAC3, drosophila rho GTPase 3; TAL, hematopoietic transcription factors; TIMP, tissue inhibitor metalloproteinase; Defh2, defensine 2; GR, glutathione reductase; SOD, superoxide dismutase; CAT, catalase; GPX5, glutathione peroxidase 5; PRDX4-5, peroxiredoxine 4 and 5; PRN, Pernin; HSP70, Heat shock protein 70.
Figure 4Schematic diagrams of physiological changes induced during bacterial infection in C. gigas larvae.
Infection impact on larval physiology was investigated through immunity (1), cellular stress (2), energetic metabolism (3) and lipid metabolism (4) using physiological, enzymatic, biochemical and molecular analysis. Results suggest that bacterial infection induce the activation of the immune response (non-self recognition (1a), NF-κB signaling pathway (1b), haematopoiesis (1d), synthesis of inhibitor of metalloproteinase, antimicrobial peptide (1c) and phagocytosis (1e) allowing the destruction of pathogenic bacteria. The production of reactive oxygen species (ROS) during the phagocytosis process was managed by antioxidant defenses (2a) and cytoprotective proteins (2b). Infection affects the feeding activity (3a) which change the energy status of larvae (decline of metabolic rate (3b), energy reserve consumption (3c), β-oxidation activation (3d) and lower lipids storage (3e)). Besides metabolic changes, fatty acid remodeling in polar lipids (4a) is associated to pathogen exposure, as suggested by changes in phosphatidylinositol and lysophosphatidylcholine composition, non-methylene–interrupted fatty acids accumulation, lower content of major C20 polyunsaturated fatty acids and activation of desaturases. Finally, infection induces the activation of phospholipase and lipoxygenase (4b) probably through NF-κB regulation (4c) to initiate eicosanoïdes and lysophosphatidic acid (LPA) pathways. See discussion for details.